65th ASH Annual Meeting & Exposition: Frontline Treatment of Newly Diagnosed, Transplant-Ineligible Multiple Myeloma Across Patient Types

-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member

denotes an abstract that is clinically relevant.

denotes that this is a recommended PHD Trainee Session.

denotes that this is a ticketed session.

Frontline Treatment of Newly Diagnosed, Transplant-Ineligible Multiple Myeloma Across Patient Types

Sponsor: Johnson & Johnson

Product Theaters

Room 3 (San Diego Convention Center)

Speaker:

Vipin Khare, MD, Johnson & Johnson

Disclosures:

No relevant conflicts of interest to declare.

For In-Person Participants Only

See more of: Product Theaters